<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11859659</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.656</article-id><article-id pub-id-type="other">EPP0533</article-id><article-id pub-id-type="pii">S0924933824006564</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Presentation</subject></subj-group></article-categories><title-group><article-title>The possible role of platelet APP processing in the pathophysiology of Alzheimer&#x02019;s Disease</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Gurrieri</surname><given-names>R.</given-names></name><xref rid="aff1530" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor0517" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Carbone</surname><given-names>M. G.</given-names></name><xref rid="aff1531" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Arone</surname><given-names>A.</given-names></name><xref rid="aff1532" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Palermo</surname><given-names>S.</given-names></name><xref rid="aff1532" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Marazziti</surname><given-names>D.</given-names></name><xref rid="aff1532" ref-type="aff">
<sup>3</sup>
</xref><xref rid="aff1533" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Gemignani</surname><given-names>A.</given-names></name><xref rid="aff1530" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="aff1530"><sup>1</sup>Department of Surgical-Medical and Molecular Pathology and Critical Care Medicine, <institution>University of Pisa</institution>, <city>Pisa</city></aff><aff id="aff1531"><sup>2</sup>Division of Psychiatry, Department of Medicine and Surgery, <institution>University of Insubria</institution>, <city>Varese</city></aff><aff id="aff1532"><sup>3</sup>Department of Clinical and Experimental Medicine, <institution>University of Pisa</institution>, <city>Pisa</city></aff><aff id="aff1533"><sup>4</sup><institution>Saint Camillus International University of Health and Medical Sciences, Unicamillus</institution>, <city>Roma</city>, <country>Italy</country></aff><author-notes><corresp id="cor0517"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="631">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S316</fpage><lpage>S316</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824006564a.pdf"/><abstract><sec id="sec3108"><title>Introduction</title><p>Alzheimer&#x02019;s disease (AD) stands as the most prevalent form of dementia. Alzheimer&#x02019;s Disease is acknowledged to have a complex origin, a gradual neurodegenerative progression, and a wide-ranging clinical profile marked primarily by progressive memory loss, cognitive decline, and various functional impairments that significantly diminish the quality of life: Key characteristics of AD encompass the presence of amyloid plaques, which are characterized by the pathological accumulation of insoluble &#x003b2;-amyloid (A&#x003b2;) aggregates within the brain tissue and blood vessel walls.Several reports have indicated the existence of cerebral abnormalities within platelets in individuals afflicted by AD.</p></sec><sec id="sec3109"><title>Objectives</title><p>The objective of this investigation was to review studies investigating the metabolism of APP in platelets among individuals with AD to identify potential dependable peripheral indicators leading to novel approaches to its management and treatment.</p></sec><sec id="sec3110"><title>Methods</title><p>A systematic review according to the PRISMA guidelines was carried out, by accessing the PubMed database up to June 2023. The authors screened the titles and the abstracts of all the potentially relevant papers on the basis of a strict list of exclusion and inclusion criteria.</p></sec><sec id="sec3111"><title>Results</title><p>A total of thirty-two studies were included. The evidence points towards the observation that AD individuals exhibit various modifications in platelet APP processing when compared to matched healthy controls, that are frequently associated with the severity of cognitive impairment and functional independence. The majority of the evidence supports changes in platelet ADAM-10 activity, &#x003b2;-secretase activity, APP ratio, a state of heightened platelet activation or hyper-responsiveness, and a potential release of platelet APP via vesicular mechanisms, which may ultimately contribute to A&#x003b2; production.</p></sec><sec id="sec3112"><title>Conclusions</title><p>Platelets offer a promising peripheral model for detecting and evaluating molecular changes associated with AD, as they hold the potential to provide vital insights into the development of an effective diagnostic tool and open doors to innovative therapeutic approaches.</p></sec><sec id="sec3113"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="1"/></counts></article-meta></front></article>